Article
Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.
International journal of cancer - 1 May 2013
Duell Eric J, Travier Noémie, Lujan-Barroso Leila, Dossus Laure, Boutron-Ruault Marie-Christine, Clavel-Chapelon Françoise, Tumino Rosario, Masala Giovanna, Krogh Vittorio, Panico Salvatore, Ricceri Fulvio, Redondo Maria Luisa, Dorronsoro Miren, Molina-Montes Esther, Huerta José M, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nick J, Allen Naomi E, Travis Ruth, Siersema Peter D, Peeters Petra H M, Trichopoulou Antonia, Fragogeorgi Eirini, Oikonomou Eleni, Boeing Heiner, Schuetze Madlen, Canzian Federico, Lukanova Annekatrin, Tjønneland Anne, Roswall Nina, Overvad Kim, Weiderpass Elisabete, Gram Inger Torhild, Lund Eiliv, Lindkvist Björn, Johansen Dorthe, Ye Weimin, Sund Malin, Fedirko Veronika, Jenab Mazda, Michaud Dominique S, Riboli Elio, Bueno-de-Mesquita H Bas
Abstract excerpt
Menstrual and reproductive factors and exogenous hormone use have been investigated as pancreatic cancer risk factors in case-control and cohort studies, but results have been inconsistent. We conducted a prospective examination of menstrual and reproductive factors, exogenous hormone use and pancreatic cancer risk (based on 304 cases) in 328,610 women from the EPIC cohort. Then, in a case-control study nested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.